In 2026, the SAFE has decisively won the pre-seed instrument debate in the United States. Carta's State of Pre-Seed Q1 2025 report shows 90 percent of pre-seed rounds on the platform used a SAFE; convertible notes account for the other 10 percent. The question for a founder today is when that 10 percent shows up and why.
Why Two Pieces of Paper Look Almost Identical, and Why That Is Misleading
A SAFE and a convertible note both promise the same headline outcome: an investor wires cash today, the company hands over equity later, and the per-share price gets set at a future priced round. Both delay the valuation conversation. Both let a founder close in days instead of months. Both fit on a single page and both are signed by founders who are too busy to model what they did.
The real divergence between the two instruments lives in what they assume about what happens next.
A SAFE assumes a priced round will happen. There is no maturity date, no interest, no repayment obligation. If the priced round never closes, the SAFE just sits on the cap table indefinitely, an unconverted obligation that quietly affects every future capital raise. The investor's downside is that the SAFE may never convert into anything.
A convertible note assumes a priced round might not happen. It is a debt instrument. It accrues interest, usually between 4 and 8 percent simple. It has a maturity date, usually 18 to 24 months from signing. If the company has not raised a priced round before the maturity date, the note is technically due. The investor can demand repayment. In practice that almost never happens, but the right exists, and the right is the point.
Investors notice this difference long before founders do. The first thing a Series A investor pulls when they receive a term sheet is the cap table. The second thing is the stack of unconverted instruments on it. SAFEs and convertible notes do not look the same at conversion, and they do not protect investors equally if the priced round arrives later than planned. The shape of the pre-priced layer is itself a signal about who has been investing in the company and what they were betting on.
What the Two Instruments Actually Encode
Before walking through the practical differences, it helps to be precise about what each one is, legally and economically. The mechanics show up in the same way every time: at conversion, on the cap table, in the founder's ownership percentage, and in the next investor's reaction to all of it.
A SAFE is a contractual right to receive equity at a future priced round, with the per-share conversion price set by the lower of (a) the priced-round price and (b) the SAFE's valuation cap. Optionally, a discount can apply. Y Combinator introduced the SAFE in late 2013 and updated it to the post-money structure in 2018. The full mechanics of a post-money SAFE, including the cap, discount, MFN clause, and the dilution math, are covered in our companion guide SAFE Notes Explained.
A convertible note is short-term corporate debt that converts to equity at a future priced round. It carries: a principal amount (the cash invested), an interest rate (typically 5 to 7 percent in 2025), a maturity date (typically 18 to 24 months), and the same conversion mechanics as a SAFE (valuation cap, optional discount). Kruze Consulting reports that the median interest rate on convertible notes held steady at 7 percent in Q1 2025, down from a high of 8 percent in Q2 2024. As Peter Walker, head of insights at Carta, noted on LinkedIn in mid-2025, even biotech and medical-device startups, which historically leaned on convertible notes, have shifted toward the SAFE in the last two years.
The single most important distinction for founders is this: a SAFE is equity-equivalent paperwork that pretends to be simple. A convertible note is debt paperwork that converts to equity if the company succeeds at raising a priced round. When the priced round happens, both convert. When it does not, the legal status of those investor claims diverges sharply.
The Comparison That Matters at Series A
The chart below shows the differences that affect founders most when a Series A term sheet finally lands.
Term | SAFE (post-money, YC 2018) | Convertible Note (standard 2026) |
|---|---|---|
Legal classification | Hybrid security, neither pure equity nor debt | Debt instrument; sits as a liability on the balance sheet until conversion |
Interest rate | None | 4 to 8 percent simple, typically 5 to 7 percent in 2025 |
Maturity date | None. SAFE can sit unconverted indefinitely | Yes, usually 18 to 24 months from signing |
Conversion trigger | Equity financing (priced round) | Equity financing (priced round) before maturity, or maturity itself |
Repayment risk if no priced round | None. Investor's downside is non-conversion | Note becomes due at maturity. Investor can theoretically demand cash back |
Founder time to close | Hours to days for a clean YC SAFE | Days to weeks; promissory-note language requires more legal review |
Friends-and-family compatibility | High; one page, no debt mechanics | Lower; debt classification raises tax and lender questions |
QSBS holding period | Uncertain. Generally not counted until SAFE converts to stock | Uncertain. Generally not counted until note converts to stock |
UK SEIS/EIS eligibility | Not eligible until conversion (which can be too late for the relief window) | Disqualifies the round from SEIS/EIS because debt rights remain |
Typical use in 2026 | 90 percent of US pre-seed rounds on Carta in Q1 2025 | 10 percent of US pre-seed; higher share at seed-bridge stage and outside the US |
The table compresses years of cap-table conversations into one view. Three of the rows do most of the work in real founder decisions: the maturity date, the QSBS treatment, and the SEIS/EIS eligibility for European deals.
The Five Cases Where a Convertible Note Still Wins in 2026
The convertible note has narrowed to a concentrated set of use cases. After spending seven years in venture and looking at the underlying paperwork on roughly a hundred startups, here are the five scenarios where the convertible note remains the right answer in 2026.
1. Bridge Rounds Between Priced Rounds
When a company has already raised a Series Seed or Series A but needs short-term capital before the next round, the convertible note is often the cleaner instrument. The investor wants protection that scales if the next round takes longer than expected. The interest rate accrues. The maturity date creates a conversation if the next round slips by a year. According to Carta's bridge round data summarized by Crunchbase News, 16.6 percent of all cash raised in Q2 2025 came via bridge rounds, up from 11.8 percent a year earlier. Convertible notes still account for a meaningful share of that pool, even though pre-seed bridges increasingly use SAFEs too.
The reason is simple. A bridge usually involves a priced-round investor wanting to top up their position with downside protection. A SAFE gives them upside without the downside lever. A convertible note gives them both.
2. Yield-Seeking Investors With Mandate Constraints
Some family offices, RIAs, and treasury-managed accounts have a mandate to hold yield-bearing instruments. They cannot legally hold a SAFE because it carries no interest. A convertible note technically pays interest (even if that interest accrues to principal at conversion) and therefore satisfies the mandate language. This is a small but persistent slice of pre-seed capital. It comes up most often in non-tech sectors and in larger angel checks (above $250,000) where the investor is funding through an entity rather than personally.
3. International Founders, Especially in Europe
This is the largest source of the remaining convertible note volume globally, and it is the area where US-centric founder guides go silent. SAFEs are a US construct. Each European jurisdiction has handled them differently.
In the United Kingdom, the standard pre-seed instrument is the Advance Subscription Agreement (ASA), not the SAFE. The reason is tax. SEIS and EIS, the UK's tax relief schemes, can return 30 to 50 percent of an investor's investment in tax credits, and HMRC requires the instrument to convert to shares within a six-month window for SEIS/EIS to apply. Convertible notes typically disqualify the round entirely from SEIS/EIS because the investor retains the right to repayment. SAFEs do not qualify until conversion, which usually arrives outside the six-month window. ASAs were designed specifically to fit the SEIS/EIS structure. This nuance is well-documented by Bird & Bird and other UK legal authorities.
In Germany, France, Switzerland, and the Benelux countries, the Convertible Loan Agreement (CLA in Germany, BSA-AIR in France) is more common than the SAFE because the local legal framework is built around debt instruments. Companies based in those jurisdictions, or US companies raising from continental European investors, often see convertible notes as the path of least resistance. Outlex's regional comparison is one of the few public guides covering this in detail.
4. Conservative Angels Who Want a Maturity Date
A subset of angel investors, especially first-time angels and friends-and-family, prefer the convertible note because the maturity date feels like protection. The angel believes that if the company does not raise a priced round in two years, they at least have a contractual claim. The reality is that in almost every case, the maturity gets extended rather than enforced because demanding repayment from an unfunded startup is rarely the right play. But the optics matter. For founders raising from this kind of investor, the convertible note can be the deal-closing instrument even though the SAFE is mechanically equivalent.
5. Lender or Debt-Covenant Requirements
Some venture debt facilities, especially those layered on top of an early seed, treat unconverted SAFEs differently than convertible notes on covenant calculations. When a startup is operating under a venture debt term sheet, the lender's covenants may favor convertible notes (which sit clearly as debt on the balance sheet) over SAFEs (which sit ambiguously between debt and equity). This is a niche case, but for founders raising venture debt early, it is worth checking the lender's preference before signing the next angel check.
The QSBS and Tax Question Most Founders Miss
Section 1202 of the IRS code, known as the Qualified Small Business Stock (QSBS) exclusion, can exempt up to $10 million or 10 times basis of capital gains from federal tax for qualifying shareholders, provided they hold the stock for at least five years. Both founders and early investors care about this, intensely, because QSBS treatment can be the difference between paying 23.8 percent federal tax on a sale and paying close to zero.
The problem for both SAFEs and convertible notes is that the IRS has not issued definitive guidance on whether the holding period starts at signing or at conversion. As Frost Brown Todd's analysis summarizes, most tax advisors take the conservative position that the five-year clock starts when the stock is actually issued, which means at the priced round. If the priced round happens 18 months after a SAFE is signed, the SAFE holder needs to hold the resulting stock for another five years to get QSBS treatment.
This is a draw between SAFE and convertible note. Neither instrument cleanly starts the QSBS clock. But the answer matters enough that for any check above $250,000 from a sophisticated investor, the QSBS treatment usually gets discussed during paperwork and may push the deal toward a priced equity round (where the QSBS clock starts unambiguously) rather than either instrument.
The Stat That Confuses Most Founders
In the global market, convertible note issuances surged to $48 billion in 2024, a robust figure that suggests convertibles are very much alive at the system level. At the same time, Carta data shows convertible notes dropping to 9 percent of pre-seed pre-priced rounds.
Both can be true. The $48 billion figure includes all convertible debt issuance globally, including substantial growth-stage convertibles, public-company convertible bonds, and bridge financing for later-stage startups. The 9 percent figure is specifically pre-seed, US, on Carta. The two are not in conflict. They are measuring different things.
For a founder making the decision today, what matters is the pre-seed number and the regional context. If you are a US-based pre-seed founder raising from US investors, the SAFE is the default with 90 percent market share. If your circumstances put you into one of the five cases above, the convertible note is back on the table.
Why the Cap Table Drives the Real Conversation
Whether a founder signs a SAFE or a convertible note, an investor's first hour at Series A diligence goes to the cap table. The instrument paperwork sits in the file; the cap table is where the conversation happens. Specifically, three things on it:
Total dilution from the pre-priced layer (sum of every SAFE and note converting at the same time, plus accrued interest on the notes)
Founder ownership at conversion (must usually be above 30 percent for the round to feel investable)
Cleanliness of the pre-priced stack (one instrument used consistently, or a stack of mismatched terms)
A founder who closes 12 separate angel checks at three different valuation caps, with a mix of SAFEs and convertible notes, is presenting a Series A investor with a cap-table cleanup project. That investor will discount the round price to compensate for the cleanup work, will want side letters with the original investors, and will spend the first three weeks of diligence on legal rather than the business. According to Healy Jones at Kruze Consulting, whose firm has advised on more than $2 billion of venture funding, the most common founder mistake is "raising multiple different SAFEs with different terms" rather than running a clean, structured pre-priced layer.
Where SeedForge Fits In
When a Series A partner pulls up a startup for diligence, the cap table is the proof artifact they read first. Two questions need to settle before they go to investment committee. First, does the founder still own enough of the company to be motivated through years of execution. Second, does the pre-priced layer look like the work of a founder who knew what they were doing, or like the cleanup left by a founder who was just signing whatever the lawyer sent over.
SeedForge was built so that the cap table proof, alongside the rest of the proof investors look for in 2026, is structured before the first investor meeting. A founder runs one 30-minute AI session that walks through fundraising history, current cap-table state, dilution model, and the investor questions that show up most often at the next round. The output is a Living Profile shared via one link. When a Series A partner opens that link, they see the SAFEs and notes already laid out, with conversion math attached, alongside everything else they would normally ask in the first three meetings. The instrument the founder signed at pre-seed matters less than whether the founder can show what it converts to.
A Practical Decision Framework
Founders making the SAFE-versus-convertible-note decision in 2026 can run through this five-question framework in under five minutes.
Are you a US-based pre-seed founder raising from US investors? Default to a YC post-money SAFE unless one of the next four answers flips.
Is the round a bridge between priced rounds? Convertible note is often cleaner because of the maturity-date conversation that comes naturally if the next round slips.
Is your investor a yield-mandated entity (RIA, family office, treasury account)? They may need a convertible note to satisfy holding-mandate language.
Are you raising in the UK and want SEIS or EIS to apply? Default to an Advance Subscription Agreement instead. In Germany, France, Switzerland, or the Benelux, default to the local CLA or BSA-AIR.
Do you have an existing venture-debt facility or covenant constraint? Confirm with the lender which instrument plays cleanly with their covenants before signing.
If none of questions 2 through 5 flip the default, the answer is the post-money SAFE. The mechanics, dilution math, and four mistakes that show up at Series A are covered in SAFE Notes Explained, and the broader question of how a founder should think about valuation at this stage is covered in Startup Valuation at Seed Stage. For a full walk through the pre-seed playbook from research to cap table, see Pre-Seed Funding: How to Raise Your First Round in 2026.
Frequently Asked Questions
Which is more founder-friendly in 2026: SAFE or convertible note?
For most US pre-seed founders, the SAFE is more founder-friendly. It carries no interest, no maturity date, and no repayment obligation. A convertible note adds debt mechanics that increase founder risk if a priced round does not arrive on schedule. The SAFE became the 90 percent default on Carta in Q1 2025 for that reason.
Can the same investor get a SAFE and a convertible note in the same round?
Technically yes. In practice, mixing instruments inside one round creates legal and conversion-math complexity that almost always hurts the founder at Series A. Most founders who try this discover the cleanup cost at conversion. Pick one instrument per round and stay disciplined about consistent terms.
Does interest on a convertible note count toward the QSBS five-year holding period?
No. Most tax advisors take the conservative position that the QSBS five-year clock starts only when the underlying stock is issued, which usually means the priced round rather than the original signing date. The accrued interest converts to additional shares but does not back-date the holding period. Confirm with a qualified tax advisor before relying on QSBS at exit.
Why do European investors still prefer convertible notes?
The legal frameworks in Germany, France, Switzerland, and the Benelux are built around debt instruments, and the SAFE is a US construct that does not map cleanly. In the UK, the issue is tax: convertible notes disqualify SEIS and EIS relief, and SAFEs do not qualify in time, so most UK rounds use Advance Subscription Agreements instead.
What happens if a convertible note hits maturity before a priced round?
In almost every real-world case, the company and the investor agree to extend the maturity date by another 12 to 24 months. Demanding cash repayment from an unfunded startup is rare because there is usually no cash to take. The risk is that an extension conversation gives the investor leverage to renegotiate terms, including the cap.
Can I convert a convertible note into a SAFE?
Yes, but only by mutual agreement with the original investor. The note holder has to agree to surrender the debt rights (interest, maturity) and accept SAFE-equivalent terms instead. This is an uncommon but useful tool when an early angel signed a note and the company later decides to standardize on SAFEs for the rest of the pre-priced layer.